CCRC Exam Prep Questions With 100% Complete Solutions.
0 view 0 purchase
Course
CCRC
Institution
CCRC
CCRC Exam Prep Questions With 100% Complete Solutions.
*
Adverse Drug Reaction (ADR)
All noxious and unintended responses to a medicinal product related to any dose
*
Adverse Event (AE)
Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceuti...
CCRC Exam Prep Questions With 100% Complete
Solutions.
*
Adverse Drug Reaction (ADR)
All noxious and unintended responses to a medicinal product related to any dose
*
Adverse Event (AE)
Any untoward medical occurrence in a patient or clinical investigation subject
administered a pharmaceutical product and which does not necessarily have a causal
relationship with this treatment--any unfavorable and unintended sign , symptom, or
disease temporally associated with the use of a medicinal product, whether or not
related to the medicinal product
*
Applicable Regulatory Requirements
Any law(s) and regulation(s) addressing the conduct of clinical trials of investigational
products
*
Audit
A systematic and independent examination of trial related activities and documents to
determine whether the evaluated trial related activities were conducted, and the data
were recorded, analyzed and accurately reported according to the protocol, sponsor's
standard operating procedures, (SOPs), Good Clinical Practice (GCP), and the
applicable regulatory requirement(s)
*
Audit Certificate
A declaration of confirmation by the auditor that an audit has taken place
*
Audit Report
A written evaluation by the sponsor's auditor of the results of the audit
*
Audit Trail
Documentation that allows reconstruction of the course of events
*
Blinding/Masking
A procedure in which one or more parties to the trial are kept unaware of the treatment
assignment(s).
*
Case Report Form (CRF)
A printed, optical, or electronic document designed to record all of the protocol required
information to be reported to the sponsor on each trial subject.
*
Clinical Trial/Study
Any investigation in human subjects intended to discover or verify the clinical,
pharmacological and/or other pharmacodynamic effects of an investigational product(s),
,and/or to identify any adverse reactions to an investigational product(s), and/or to study
absorption, distribution, metabolism, and excretion of an investigational product(s) with
the object of ascertaining its safety and/or efficacy
*
Clinical Trial/Study Report
A written description of a trial/study of any therapeutic, prophylactic, or diagnostic agent
conducted in human subjects, in which the clinical and statistical description,
presentations, and analyses are fully integrated into a single report
*
Comparator (Product)
An investigational or marketed product, or placebo, used as a reference in a clinical
trial.
*
Confidentiality
Prevention of disclosure, to other than authorized individuals, of a sponsor's proprietary
information or of a subject's identity.
*
Contract
A written, dated, and signed agreement between two or more involved parties that sets
out any arrangements on delegation and distribution of tasks and obligations and, if
appropriate, on financial matters.
*
Coordinating Committee
A committee that a sponsor may organize to coordinate the conduct of a multicenter
trial.
*
Coordinating Ivestigator
An investigator assigned the responsibility for the coordination of investigators at
different centers participating in a multicenter trial
*
Contract Research Organization (CRO)
A person or an organization (commercial, academic, or other) contracted by the sponsor
to perform one or more of a sponsor's trial-related duties and functions.
*
Direct Access
Permission to examine, analyze, verify, and reproduce any records and reports that are
important to evaluation of a clinical trial
*
Documentation
All records, in any form that describe or record the methods, conduct, and/or results of a
trial, the factors affecting a trial, and the actions taken
*
Essential Documents
Documents which individually and collectively permit evaluation of the conduct of a
study and the quality of the data produced
,*
Good Clinical Practice (GCP)
A standard for the design, conduct, performance, monitoring, auditing, recording,
analyses, and reporting of clinical trials that provides assurance that the data and
reported results are credible and accurate, and that the rights, integrity, and
confidentiality of trial subjects are protected
*
Independent Data-Monitoring Committee (IDMC) (Data and Safety Monitoring
Board, Monitoring Committee, Data Monitoring Committee)
An independent data-monitoring committee that may be established by the sponsor to
assess at intervals the progress of a clinical trial, the safety data, and the critical efficacy
endpoints, and to recommend to the sponsor whether to continue, modify, or stop a trial
*
Impartial Witness
A person, who is independent of the trial, who cannot be unfairly influenced by people
involved with the trial, who attends the informed consent process if the subject or the
subject's legally acceptable representative cannot read, and who reads the informed
consent form and any other written information supplied to the subject
*
Independent Ethics Committee (IEC)
An independent body constituted of medical professionals and non-medical members,
whose responsibility it is to ensure the protection of the rights, safety and well-being of
human subjects involved in a trial and to provide public assurance of that protection, by,
among other things, reviewing and approving / providing favorable opinion on, the trial
protocol, the suitability of the investigator(s), facilities, and the methods and material to
be used in obtaining and documenting informed consent of the trial subjects.
*
Informed Consent
A process by which a subject voluntarily confirms his or her willingness to participate in
a particular trial, after having been informed of all aspects of the trial that are relevant to
the subject's decision to participate--documented by means of a written, signed and
dated informed consent form
*
Inspection
The act by a regulatory authority of conducting an official review of documents, facilities,
records, and any other resources that are deemed by the authorities to be related to the
clinical trial and that may be located at the site of the trial, at the sponsor's and/or
contract research organization's (CRO's) facilities, or at other establishments deemed
appropriate by the regulatory authorities
*
Interim Clinical Trial/Study Report
A report of intermediate results and their evaluation based on analyses performed
during the course of a trial
*
Investigational Product
, A pharmaceutical form of an active ingredient or placebo being tested or used as a
reference in a clinical trial, including a product with a marketing authorization when used
or assembled (formulated or packaged) in a way different from the approved form, or
when used for an unapproved indication, or when used to gain further information about
an approved use.
*
Investigator
A person responsible for the conduct of the clinical trial at a trial site.
*
Investigator's Brochure
A compilation of the clinical and nonclinical data on the investigational product(s) which
is relevant to the study of the investigational product(s) in human subjects.
*
Legally Acceptable Representative
An individual or juridical or other body authorized under applicable law to consent, on
behalf of a prospective subject, to the subject's participation in the clinical trial.
*
Monitoring
The act of overseeing the progress of a clinical trial, and of ensuring that it is conducted,
recorded, and reported in accordance with the protocol, Standard Operating Procedures
(SOPs), Good Clinical Practice (GCP), and the applicable regulatory requirement(s).
*
Monitoring Report
A written report from the monitor to the sponsor after each site visit and/or other trial-
related communication according to the sponsor's SOPs.
*
Nonclinical Study
Biomedical studies not performed on human subjects
*
Quality Assurance (QA)
All those planned and systematic actions that are established to ensure that the trial is
performed ad the data are generated, documented, and reported in compliance with
GCP and the applicable regulatory requirements
*
Quality Control (QC)
The operational techniques and activities undertaken within the quality assurance
system to verify that the requirements for quality of the trial-related activities have been
fulfilled
*
Serious Adverse Event (SAE) or Serious Adverse Drug Reaction (Serious ADR)
Any untoward medical occurrence that at any dose:
-results in death
-is life-threatening
-requires inpatient hospitalization or prolongation of existing hospitalization
-results in persistent or significant disability/incapacity
-is a congenital anomaly/birth defect
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller LectDan. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $15.49. You're not tied to anything after your purchase.
